CMS proposes changes to dual-eligible risk adjustment model; Medicaid directors warned against restricting access to hep C drugs;

News From Around the Web

> In response to concerns about the CMS-Hierarchical Condition Category risk adjustment model for predicting costs of dual eligible beneficiaries, the Centers for Medicare & Medicaid Services is proposing changes to the model in order to "improve the predictive ratios for full benefit and partial benefit dual-eligible beneficiaries in the community." Announcement

> While MNsure has named Mark Nyquist as the finalist to become the Minnesota exchange's new CEO, as MPR News reports, a prominent Republican lawmaker in the state accused MNsure's current executives of misleading him about their budget, according to the St. Paul Pioneer Press. Article

> In a notice to state Medicaid directors, the Centers for Medicare & Medicaid Services warns them not to impose conditions for coverage that could unreasonably restrict beneficiaries' access to hepatitis C drugs. Notice

Health Finance News

> Healthcare executives saw salary increases in 2015 even as chief executive officer and chief financial officer salaries in publicly-traded companies in general saw slower growth, due in large part to the increasingly consumer-centered healthcare market, according to a new study. Article

Healthcare News

> Efforts to fight hospital-acquired conditions are succeeding, with the number of cases falling by 17 percent between 2011 and 2013, according to a study published this week by the Agency for Healthcare Research and Quality. Article

And finally… Australia, where even the clouds are scary. Article

Suggested Articles

Hospitals are already signaling a legal challenge to a final rule from CMS on price transparency, but the agency is ready.

It is time to fight fraud and waste the right way: by reducing burdens on providers, streamlining oversight and putting patients over paperwork.

CMS issued a proposed rule and a final rule aimed at increasing price transparency from hospitals and insurers.